AI and digital adoption for R&D and commercial productivity
8 statements on the record across 3 companies, ordered by how much each has said. Every quote is verbatim from its call.
Across the group, large-cap biopharma companies describe AI as a lever for both R&D and commercial productivity, though the emphasis differs by company. AMGN highlights infrastructure investment, opening a global technology and innovation center in Hyderabad to build AI, data science and automation capabilities that Griffith says now span molecule design, trial enrollment, regulatory filings and commercial responsiveness [m2381, m2493, m2491], with Bradway framing AI as helping find new opportunities and deliver medicines faster [m2470]. PFE centers its AI narrative on organizational restructuring, with Bourla pointing to research units tapping enterprise-wide AI-powered discovery tools [m2213] and a consolidated single advertising partner using AI to reshape marketing and selling [m2210], while Denton later broadens this to boosting R&D productivity, prioritizing programs and pursuing growth via business development [m2334]. BMY takes a narrower efficiency angle, with CFO Elkins stating the company continues to leverage AI to further automate operations [m2305]. No company provides quantified productivity targets or new dated commitments beyond AMGN's hub becoming operational by 2025 [m2493].
Griffith stated Amgen is opening a new global technology and innovation center in Hyderabad, India to accelerate digital capabilities including AI, data science, life science and medical. [m2381] By 2025, Griffith described this India hub as newly established and now leveraged alongside automation to drive efficiencies and prioritize resources. [m2381, m2493] Bradway stated AI is helping Amgen find new opportunities across the business and deliver innovative medicines to more patients even faster. [m2470] Griffith stated Amgen deploys AI across the value chain, including molecule design and discovery research, faster trial enrollment, streamlined regulatory filings, and enhanced commercial responsiveness. [m2491]
Show the 4 verbatim statements
#m2381 · 2024-08-06 · Peter Griffith · STATED
“Beyond manufacturing, we are opening a new global technology and innovation center in Hyderabad, India, which will attract talent at scale and accelerate digital capabilities across the organization, including artificial intelligence, data science, life science and medical.”
#m2493 · 2025-02-04 · Peter Griffith · STATED
“as we continue to drive efficiencies and prioritize resources, including leveraging both automation and our newly established innovation and technology hub in India.”
#m2470 · 2025-02-04 · Robert Bradway · STATED
“When it comes to artificial intelligence, we're finding new opportunities across our business, and AI is helping us deliver innovative medicines to more patients even faster.”
#m2491 · 2025-02-04 · Peter Griffith · STATED
“Our commitment to innovation is also evident as we deploy artificial intelligence across the value chain, including informing molecule design and discovery research, enabling faster trial enrollment and streamlining regulatory filings in clinical development, and enhancing our responsiveness to customers in commercial operations.”
Bourla said Pfizer's restructured research units tap enterprise-wide AI-powered drug discovery and development capabilities. [m2213] Bourla also said Pfizer consolidated external agencies into one advertising partner and leverages AI to transform marketing and selling. [m2210] Denton later broadened the AI ambition, aiming to boost R&D productivity with digital tools including AI, prioritize key R&D programs, and deliver growth via business development. [m2334]
Show the 3 verbatim statements
#m2213 · 2025-02-04 · Albert Bourla · STATED
“This structure fully empowers research units that can operate with a focus and agility of a biotech company, while tapping into our differentiated enterprise-wide capabilities such as AI-powered drug discovery and development.”
#m2210 · 2025-02-04 · Albert Bourla · STATED
“They consolidated our external agencies down to one powerhouse global advertising company and leverage the power of AI to transform our marketing and selling engine.”
#m2334 · 2025-11-04 · David Denton · STATED
“We aim to boost R&D productivity with digital tools, including AI, prioritize investments in key R&D programs and to deliver new growth through business development.”
CFO David Elkins stated BMY continues to leverage AI and aims to further automate operations, increasing efficiency. [m2305]
Show the 1 verbatim statement
#m2305 · 2025-04-24 · David Elkins · STATED
“we continue to leverage AI and look to further automate, which is making us even more efficient.”
OPEN is an unresolved commitment on the clock; STATED is on the record without a checkable bar and is never counted or scored. Method: methodology.